EA200701433A1 - RECEIVING IRBISARTANA - Google Patents

RECEIVING IRBISARTANA

Info

Publication number
EA200701433A1
EA200701433A1 EA200701433A EA200701433A EA200701433A1 EA 200701433 A1 EA200701433 A1 EA 200701433A1 EA 200701433 A EA200701433 A EA 200701433A EA 200701433 A EA200701433 A EA 200701433A EA 200701433 A1 EA200701433 A1 EA 200701433A1
Authority
EA
Eurasian Patent Office
Prior art keywords
irbisartana
receiving
pharmaceutically acceptable
irbesartan
salt
Prior art date
Application number
EA200701433A
Other languages
Russian (ru)
Other versions
EA012852B1 (en
Inventor
Силво Зупанциц
Аница Пецавар
Рок Зупет
Original Assignee
Крка, Товарна Здравил, Д. Д., Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200500004A external-priority patent/SI21964A/en
Application filed by Крка, Товарна Здравил, Д. Д., Ново Место filed Critical Крка, Товарна Здравил, Д. Д., Ново Место
Publication of EA200701433A1 publication Critical patent/EA200701433A1/en
Publication of EA012852B1 publication Critical patent/EA012852B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Настоящее изобретение относится к способу получения ирбесартана или его фармацевтически приемлемых солей, включающему синтез тритилирбесартана с помощью реакции 5-(4-(бромометил)бифенил-2-ил)-1-(трифенилметил)тетразола и 2-н-бутил-4-циклопентан-2-имидазолин-5-она или его соли в органическом растворителе в присутствии катализатора межфазного переноса и основания, удаление защитной группы и выделение ирбесартана или его фармацевтически приемлемой соли.The present invention relates to a method for producing irbesartan or its pharmaceutically acceptable salts, including the synthesis of tritylrbesartan using the reaction of 5- (4- (bromomethyl) biphenyl-2-yl) -1- (triphenylmethyl) tetrazole and 2-n-butyl-4-cyclopentane -2-imidazolin-5-one or its salt in an organic solvent in the presence of a phase transfer catalyst and a base, removal of the protective group and isolation of irbesartan or its pharmaceutically acceptable salt.

EA200701433A 2005-01-05 2006-01-04 Preparation of irbesartan EA012852B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200500004A SI21964A (en) 2005-01-05 2005-01-05 Preparation of tetrazole derivative
SI200500132A SI21965A (en) 2005-01-05 2005-05-05 Preparation of tetrazole derivative
PCT/SI2006/000001 WO2006073376A2 (en) 2005-01-05 2006-01-04 Preparation of irbesartan

Publications (2)

Publication Number Publication Date
EA200701433A1 true EA200701433A1 (en) 2008-02-28
EA012852B1 EA012852B1 (en) 2009-12-30

Family

ID=36129763

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701433A EA012852B1 (en) 2005-01-05 2006-01-04 Preparation of irbesartan

Country Status (5)

Country Link
EP (1) EP2049527A2 (en)
EA (1) EA012852B1 (en)
NO (1) NO20073984L (en)
SI (1) SI21965A (en)
WO (1) WO2006073376A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1916246A3 (en) * 2006-10-11 2008-06-18 Cadila Pharmaceuticals Limited An improved process for the preparation of olmesartan medoxomil
GB0700993D0 (en) * 2007-01-18 2007-02-28 Rainbow Engineering Services Novel compounds
GB0700992D0 (en) * 2007-01-18 2007-02-28 Rainbow Engineering Services Novel compounds
EP2194050A1 (en) 2008-12-08 2010-06-09 KRKA, tovarna zdravil, d.d., Novo mesto A new process for the preparation of irbesartan

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE340793T1 (en) * 2002-07-16 2006-10-15 Teva Pharma NEW SYNTHESIS OF IRBESARTAN
CN101165062A (en) * 2003-01-16 2008-04-23 特瓦制药工业有限公司 Novel synthesis of irbesartan
EP1590343B1 (en) * 2003-02-05 2008-07-16 Teva Pharmaceutical Industries Limited Synthesis of 2-butyl-3-(2' -(1-trityl-1h-tetrazol-5-yl)biphen yl-4-yl)-1,3-diazaspiro-4,4 -nonene-4-one
SI21849A (en) * 2004-07-29 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Preparation of hydrochloride salts of tetrazole derivative

Also Published As

Publication number Publication date
WO2006073376A2 (en) 2006-07-13
WO2006073376A3 (en) 2006-09-21
NO20073984L (en) 2007-10-05
SI21965A (en) 2006-08-31
EA012852B1 (en) 2009-12-30
EP2049527A2 (en) 2009-04-22

Similar Documents

Publication Publication Date Title
NO20060729L (en) Process for the preparation of tetrazole derivatives from organic boron and aluminum azides
MY146795A (en) Process for the synthesis of organic compounds
ATE555105T1 (en) HETEROCYCLIC FXR BINDING COMPOUNDS
TN2010000052A1 (en) PYRAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF RAF
NO20060900L (en) Nitrooside derivatives of Losartan, Valsartan, Candesartan, Telmisartan, Eprosartan and Olmesartan as angiotensin II receptor blockers for the treatment of cardiovascular disease
CO6361856A2 (en) JAK AND METHOD INHIBITING PIRAZOLOPIRIMIDINE COMPOUNDS
AR049681A1 (en) MACROLIDS PREPARED FROM ACTINOMICETS. PHARMACEUTICAL COMPOSITIONS
NO20062021L (en) Redirected pentanols, their methods of preparation, and their use as antiflogistics
DK1578733T3 (en) Process for the preparation of rosuvastatin
NO20070368L (en) Viral polymerase inhibitors
ATE402173T1 (en) STEREOSELECTIVE SYNTHESIS OF CERTAIN TRIFLUOROMETHYL-SUBSTITUTED ALCOHOLS
NO20070608L (en) Use of 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
GT200600207A (en) PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS
NO20071254L (en) Process for the preparation of irbesartan and its intermediates.
CR11824A (en) HETEROCYCLIC DERIVATIVES OF UREA AND ITS EMPLOYMENT METHODS
EA200701433A1 (en) RECEIVING IRBISARTANA
DE602006021327D1 (en) ISOCHINOLINE AS IGF-1R INHIBITORS
EA200700550A1 (en) DERIVATIVES OF ALKYLIDENTETRAHYDRONAPTALINE, METHOD OF THEIR RECEIVING AND THEIR APPLICATION AS ANTI-INFLAMMATORY MEANS
CY1110688T1 (en) PROCEDURE FOR PREPARATION OF CARVEDIOLOL AND ANTIOMOMETER
NO20062022L (en) 1- (quinolinamino) - and 1- (isoquinolinamino) -substituted pentan-2-oils, process for their preparation and use of it as anti-inflammatory agents
CL2010000254A1 (en) Procedure for the synthesis of ivabradine by formation of an imine; and the intermediate compounds considered in the process.
UA88501C2 (en) Preparation of irbesartan
UA90131C2 (en) Method for the production of losartan
WO2007057919A3 (en) An improved process for preparation of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU